These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 20427265)

  • 1. Glycosylphosphatidylinositol anchor analogues sequester cholesterol and reduce prion formation.
    Bate C; Tayebi M; Williams A
    J Biol Chem; 2010 Jul; 285(29):22017-26. PubMed ID: 20427265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoacylated cellular prion protein modifies cell membranes, inhibits cell signaling, and reduces prion formation.
    Bate C; Williams A
    J Biol Chem; 2011 Mar; 286(11):8752-8. PubMed ID: 21212283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sialic Acid on the Glycosylphosphatidylinositol Anchor Regulates PrP-mediated Cell Signaling and Prion Formation.
    Bate C; Nolan W; Williams A
    J Biol Chem; 2016 Jan; 291(1):160-70. PubMed ID: 26553874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glimepiride reduces the expression of PrPc, prevents PrPSc formation and protects against prion mediated neurotoxicity in cell lines.
    Bate C; Tayebi M; Diomede L; Salmona M; Williams A
    PLoS One; 2009 Dec; 4(12):e8221. PubMed ID: 20011040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the tail wag the dog? How the structure of a glycosylphosphatidylinositol anchor affects prion formation.
    Bate C; Nolan W; Williams A
    Prion; 2016 Mar; 10(2):127-30. PubMed ID: 26901126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A glycosylphosphatidylinositol analogue reduced prion-derived peptide mediated activation of cytoplasmic phospholipase A2, synapse degeneration and neuronal death.
    Bate C; Tayebi M; Williams A
    Neuropharmacology; 2010; 59(1-2):93-9. PubMed ID: 20398681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cellular prion protein with a monoacylated glycosylphosphatidylinositol anchor modifies cell membranes, inhibits cell signaling and reduces prion formation.
    Bate C; Williams A
    Prion; 2011; 5(2):65-8. PubMed ID: 21738009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clustering of sialylated glycosylphosphatidylinositol anchors mediates PrP-induced activation of cytoplasmic phospholipase A 2 and synapse damage.
    Bate C; Williams A
    Prion; 2012; 6(4):350-3. PubMed ID: 22895089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Docosahexaenoic and eicosapentaenoic acids increase prion formation in neuronal cells.
    Bate C; Tayebi M; Diomede L; Salmona M; Williams A
    BMC Biol; 2008 Sep; 6():39. PubMed ID: 18789130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequestration of free cholesterol in cell membranes by prions correlates with cytoplasmic phospholipase A2 activation.
    Bate C; Tayebi M; Williams A
    BMC Biol; 2008 Feb; 6():8. PubMed ID: 18269734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Squalestatin cures prion-infected neurons and protects against prion neurotoxicity.
    Bate C; Salmona M; Diomede L; Williams A
    J Biol Chem; 2004 Apr; 279(15):14983-90. PubMed ID: 14754889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurodegeneration induced by clustering of sialylated glycosylphosphatidylinositols of prion proteins.
    Bate C; Williams A
    J Biol Chem; 2012 Mar; 287(11):7935-44. PubMed ID: 22262833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phospholipase A2 inhibitors or platelet-activating factor antagonists prevent prion replication.
    Bate C; Reid S; Williams A
    J Biol Chem; 2004 Aug; 279(35):36405-11. PubMed ID: 15210691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glypican-1 mediates both prion protein lipid raft association and disease isoform formation.
    Taylor DR; Whitehouse IJ; Hooper NM
    PLoS Pathog; 2009 Nov; 5(11):e1000666. PubMed ID: 19936054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion of raft associated prion protein to the protease-resistant state requires insertion of PrP-res (PrP(Sc)) into contiguous membranes.
    Baron GS; Wehrly K; Dorward DW; Chesebro B; Caughey B
    EMBO J; 2002 Mar; 21(5):1031-40. PubMed ID: 11867531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Removal of the glycosylphosphatidylinositol anchor from PrP(Sc) by cathepsin D does not reduce prion infectivity.
    Lewis PA; Properzi F; Prodromidou K; Clarke AR; Collinge J; Jackson GS
    Biochem J; 2006 Apr; 395(2):443-8. PubMed ID: 16441239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The glycosylphosphatidylinositol anchor is a major determinant of prion binding and replication.
    Bate C; Tayebi M; Williams A
    Biochem J; 2010 Apr; 428(1):95-101. PubMed ID: 20196773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoskeleton-dependent clustering of membrane-bound prion protein on the cell surface.
    Hackl S; Ng XW; Lu D; Wohland T; Becker CFW
    J Biol Chem; 2021; 296():100359. PubMed ID: 33539927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prion protein and lipid rafts.
    Taylor DR; Hooper NM
    Mol Membr Biol; 2006; 23(1):89-99. PubMed ID: 16611584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PrP Knockout Cells Expressing Transmembrane PrP Resist Prion Infection.
    Marshall KE; Hughson A; Vascellari S; Priola SA; Sakudo A; Onodera T; Baron GS
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27847358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.